NCT01469247View on ClinicalTrials.gov

Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 7, 2011

Primary Completion Date

September 20, 2022

Study Completion Date

September 20, 2022

Conditions
Brain Cancer
Interventions
RADIATION

Radiation Therapy

Starting Dose 24 Gy in 2 Gy fractions.

Trial Locations (2)

32806

Orlando Health, Orlando

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT01469247 - Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT) | Biotech Hunter | Biotech Hunter